share_log
Reuters ·  Sep 20, 2024 04:07
Notable Labs Ltd - Approved Immediately Pausing Implementation of Planned Phase 2 Study of Volasertib in Relapsed/Refractory Aml (R/R Aml)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment